# Report on the Medicinal Use of Eleven Lamiaceae Species in Lebanon and Rationalization of Their Antimicrobial Potential by Examination of the Chemical Composition and Antimicrobial Activity of Their Essential Oils

Authors: Madona Khoury; Didier Stien; Véronique Eparvier; Naïm Ouaini; Marc El Beyrouthy
Journal: Evidence-Based Complementary and Alternative Medicine
 (2016)

---

## Abstract

Many Lamiaceae species are consumed in the Lebanese cuisine as food or condiment and are largely used in the traditional medicine of Lebanon to treat various diseases, including microbial infections. In this article we report the traditional medicinal uses of eleven Lamiaceae species:Coridothymus capitatus L.,Lavandula stoechas L.,Lavandula angustifolia Mill.,Mentha spicata L. subsp.condensata,Origanum syriacum L.,Rosmarinus officinalis,Salvia fruticosa Miller.,Satureja cuneifolia Ten.,Satureja thymbra L.,Thymbra spicata L., andVitex agnus-castus L. and study the chemical composition and antimicrobial activity of their essential oils (EOs). Our survey showed that Lamiaceae species are mainly used against gastrointestinal disorders and microbial infections. Chemical analysis of the EOs obtained from these plants allowed us to identify seventy-five compounds describing more than 90% of the relative composition of each EO. Essential oils with high amounts of thymol and carvacrol possessed the strongest antimicrobial activity. As expected, these two compounds demonstrated an interesting antifungal efficacy against the filamentous fungusT. rubrum. Our results confirmed that some of the Lamiaceae species used in Lebanon ethnopharmacological practices as antimicrobial agents do possess antibacterial and antifungal potential consistent with their use in alternative or complementary medicine.


---

## Body

## 1. Introduction

The evolution of resistance to currently used antimicrobial compounds is neither a surprising nor a new phenomenon; however, infections are becoming more common, more severe, and more easily transmitted. According to the WHO, many infectious diseases will become untreatable and uncontrollable in the upcoming years [1]. Many authors mention a possible upcoming postantibiotic era [2–4].Aromatic plants have been recognized since antiquity and widely used as bactericides, fungicides, virucides, antiparasitics, and pesticides. Their properties are mainly attributed to their volatile oils [5, 6]. Investigations into the antimicrobial activities, mode of action, and potential uses of plant essential oils have regained momentum [7]. These oils, representative of very wide chemical diversity, may contribute to or inspire alternative solutions against multidrug resistant infections. Recently,in vitro screening programs based on ethnobotanical approaches proved to be very efficient in validating traditional uses of medical plants and providing new ways in the search for active compounds [8].Lamiaceae (formerly known as Labiatae) is a large plant family of mostly shrubs and herbs. It is the largest family of the order Lamiales with 236 genera and more than 7,000 species, the largest genus beingSalvia with around 900 species [9]. Lamiaceae are distributed globally and a particularly high concentration of them occurs in the Mediterranean region. The majority of Lamiaceae being aromatic plants, the family is economically important [10]. Many are cultivated as ornamentals, likeAjuga, Coleus, andSalvia but others are widely used as culinary herbs and spices, such as sage (Salvia), thyme (Thymus), mint (Mentha), oregano or marjoram (Origanum), rosemary (Rosmarinus), lavender (Lavandula), and basil (Ocimum). Mint and lavender are grown for their oil used in perfumery, cosmetics, pharmaceutical, and food industries as active ingredients or as flavour and fragrance. Medicinal properties of the Lamiaceae species are often attributed to their high content of volatile compounds.The Lamiaceae family is particularly well represented in Lebanon, where 136 species belonging to 29 genera have been inventoried [11]. Many Lamiaceae are regularly consumed in the Lebanese cuisine as food or condiments. For example, the different varieties of thyme likeOriganum syriacum,Satureja thymbra, andThymbra spicata associated with a mixture ofRhus coriaria L. (sumac) and sesame seeds are the main ingredients of a very popular Lebanese pizza called “manakeesh.” Others, likeRosmarinus officinalis,Coridothymus capitatus, andSalvia fruticosa, are eaten as salads and the leaves ofThymus andOriganum species are mixed with traditional Lebanese fresh cheese called “Shanklish” for their aromatic and antiparasitic properties.Indigenous Lamiaceae are also frequently used in Lebanon for medical purposes and are marketed by herbalists. These include the generaLavandula,Melissa,Mentha,Origanum,Rosmarinus,Salvia,Satureja, andThymus. These plants are highly aromatic due to the presence of external glandular structures that produce volatile oil [12] and their essential oils are widely used in the Lebanese folk medicine [11, 13, 14].However, there was no previous study documenting the folk medicinal usage of the Lamiaceae species in Lebanon. We have conducted a large-scale survey on the traditional medicinal uses of Lamiaceae species in different regions of Lebanon. A part of this work has already appeared in a congress report [11].The main objectives of the present study were (1) to report on the traditional uses of eleven Lamiaceae species most used in the Lebanese folk medicine (Coridothymus capitatus L. Reichenb. Fil.,Lavandula stoechas L.,Lavandula angustifolia Mill.,Mentha spicata L. subsp.condensata,Origanum syriacum L.,Rosmarinus officinalis L.,Salvia fruticosa Miller.,Satureja cuneifolia Ten.,Satureja thymbra L.,Thymbra spicata L., andVitex agnus-castus L.), (2) to investigate the chemical composition of the EOs extracted from these species, (3) to evaluate the antimicrobial activity of these EOs and their major constituents against opportunistic human pathogens, and (4) to correlatein vitro results with the ethnopharmacological uses of these plants.


## 2. Material and Methods

### 2.1. Ethnomedical Field Survey and Ethnobotanical Data Collection

The research was carried out in different regions of Lebanon from the north to the south and from the coast to the mountains, including the anti-Lebanon mountain range and the steppe. A great variety of wild plant species according to different ecological conditions can therefore be found. The surveys were conducted in the cities and villages of the twenty-five districts (“aqdya” or “qadaa”) of the six governorates (“mohaafazah”) of Lebanon (Figure1).Figure 1
Studied area: the governorates and districts of Lebanon.Ethnobotanical and ethnomedicinal information was obtained between the years 2002 and 2008 from 325 interviewees from 223 villages covering all the districts of Lebanon. Most of the participants interviewed were herbalists (“Attarin” or “dabbous”), shepherds, farmers, folk healers, or older experienced people and midwives (“daye”) between 40 and 70 years old. The people interviewed declared that their knowledge about the traditional medicine was transmitted mainly orally from older generations. Interviewees were accompanied to the field individually where they would point out the herbs that have been using to cure the mentioned disease. This was also to confirm plant identification (vernacular names can be different in different regions of Lebanon) and obtain fresh samples for herbarium voucher. When the fertile part was not available, the plant was visited again at the appropriate time to obtain a fertile sample.The obtained information was cross-checked with that of other informants, and also, after a week, the interview was repeated with the same person. Only medical usages of plants given at least by three separate informants have been reported in this investigation. It was verified that each informant is able to recognize the mentioned plant species in the wild.The questionnaire form was based on the botanical and ethnopharmacognosic survey of traditional medicine plants, suggested by WHO [15]. The collected information included local names, used part(s) of the plant, folk medicinal uses and therapeutic properties, method of preparation, way of administration, doses, and duration of treatment. The results are recorded in a synoptic table (Table 2).


### 2.2. Plant Material

Plant material was collected in several locations throughout Lebanon and voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon. Specimens of the Lamiaceae species were collected as described in Table1.Table 1
Plant material collection information.
Plant name
Part used
Collection region
Collection date
Voucher number
Region
District
GPS Location
Altitude (m)
Coridothymus capitatus
Flowering tops
Anfeh
Koura
34°21′38.69′′N35°43′58.96′′E
8
August 2011
MNV191a
Lavandula angustifolia
Flowering tops
Qartaba
Mount Lebanon
34°05′39.18′′N35°50′38.99′′E
1170
May 2012
MNC121
Lavandula stoechas
Flowering tops
Adonis
Keserwan
33°58′05.91′′N35°36′35.20′′E
50
May 2012
MNV114
Mentha spicata
Flowering tops
Kfarzebian
Mount Lebanon
33°59′53.43′′N35°51′29.69′′E
2015
July 2012
MNV194
Satureja cuneifolia
Leaves
MNV173
Origanum syriacum
Flowering tops
Alita
Keserwan
34°05′29.72′′N35° 41′27.05′′E
620
August 2012
MNV188
Rosmarinus officinalis
Leaves
Shuwayfat
Mount Lebanon
34°48′32.43′′N33°48′32.43′′E
200
October 2011
MNV154
Salvia fruticosa
Leaves
Nahr Ibrahim
Mount Lebanon
34°04′24.34′′N35°39′19.03′′E
190
June 2012
MNV159
Satureja thymbra
Flowering tops
MNV173a
Thymbra spicata
Leaves
MNV191
Vitex agnus-castus
Flowering tops
Nahr Ibrahim
Mount Lebanon
34°03′42.70′′N35°38′44.52′′E
7
June 2012
MNV096Table 2
Traditional remedies from Lamiaceae plant species in Lebanon.
Scientific name
Common name
Vernacular names in Lebanon
Part used
Preparation
Traditional medicinal indication in Lebanon
N
Fr (%)
Coridothymus capitatus (L.) Reichenb. Fil
Conehead Thyme
Za’atar farisiZa’atar ‘assalZa’atar
Fp
I: infusion or decoction on an empty stomach, one cup in the morning
Gastrointestinal disorders (colics, gastritis, stomach aches, carminative) (5, 6, 9, 15)
16
4.9
Antidiarrheal (6, 15)
6
1.8
Antiemetic (5, 9)
5
1.5
Antihypertensive (6, 9)
6
1.8
Vermifuge (5, 6, 15)
4
1.2
Spasmolytic (15)
5
1.5
Acne (9)
4
1.2
Antiseptic (6, 9, 15)
9
2.8
I: cold infusion
Dermatosis (5, 15)
4
1.2
Le
I: infusion, 1 teaspoon in a cup of water, drinking 3 cups per day
Cough, pneumonia, expectorant (5, 6, 15)
8
2.5
Hypoglycemic (6, 15)
5
1.5
Stomachic (5, 6)
6
1.8
Febrifuge (6)
3
0.9
Lavandula stoechas L.
Spanish lavender
Astakhoudos KhuzamaShih
Fp
I: infusion, 1 or 2 cups per day
Antiseptic (2, 9, 12, 20, 22)
10
3.1
Gastrointestinal disorders (9, 12, 20)
7
2.1
Spasmolytic (12, 17, 22)
5
1.5
Rheumatism (2, 20)
6
1.8
Cardiotonic (9, 17, 22)
6
1.8
Lavandula angustifolia Mill. (c
u
l
t
i
v
a
t
e
d
∗)
Common lavender or English lavender
KhuzamaLawanda
FpLeSt
I: infusion, 2 cups per day
Hypoglycemic (6, 12, 14, 18, 20)
10
3.1
Antihypertensive (12, 18, 20)
9
2.8
Hepatitis (14, 20)
7
2.1
Antiseptic (6, 14, 18)
9
2.8
Dermatitis (6, 18, 20)
8
2.5
Migraine (12, 18)
3
0.9
Flu (14, 18)
4
1.2
Asthenia, stimulant (14, 20)
5
1.5
Stomachic, antispasmodic, carminative (6, 12, 14, 18)
11
3.4
Sedative (6, 12, 20)
4
1.2
Uricemia (12)
3
0.9
Diuretic (12, 18)
6
1.8
E: EO massage
Healing (14, 17)
8
2.5
Rheumatism (14, 17)
9
2.8
Lumbago (17)
4
1.2
Mentha spicata L. subsp. condensata (Briq.) Greuter & Burdet
Wild mint
Na’ana’a barri
Le
I: infusion
Digestive disorders (12, 17, 20, 24, 25)
12
3.7
Antimicrobial (12, 20, 25)
9
2.8
Gastritis (17, 24, 25)
5
1.5
Antiemetic (17, 24)
4
1.2
Arthritis (12, 20)
4
1.2
Origanum syriacum L.
Biblical-hyssop, Lebanese oregano, or Syrian oregano
Zouba’ Za’atar
Fp
I: decoction mixed with honey 2 cups per day; food mixtures
Antiseptic, antimicrobial (1, 8, 10, 11, 12, 13, 14, 26)
15
4.6
Vermifuge (8, 11, 14)
8
2.5
Pertussis (10, 12, 13)
6
1.8
Antihypertensive (1, 10, 14, 26)
10
3.1
Hypoglycemic (11, 12, 13)
7
2.1
Stomachic (1, 13, 14, 26)
9
2.8
Spasmolytic (8, 11, 12)
7
2.1
Antidiarrheal (11, 13, 14)
8
2.5
Rheumatism (1, 12, 26)
8
2.5
Asthma (1, 8)
7
2.1
Migraine (13, 14)
6
1.8
Appetizer (8, 26)
5
1.5
Stimulating memory (13)
6
1.8
Le
I: infusion 20 g/L; 250–500 mL/day
Cough, expectorant (2, 9)
6
1.8
Vermifuge (2)
5
1.5
Constipation (9)
3
0.9
I: infusion, drinking daily
Bronchitis (18, 22)
4
1.2
Hypoglycemia (22)
3
0.9
I: infusion, 1 teaspoon in a cup of water
Antihypertensive (12, 14)
6
1.8
Gastrointestinal disorders (8, 12, 14)
8
2.5
E: local application mixed with olive oil
Analgesic (2, 14)
6
1.8
Rheumatism (2, 12)
6
1.8
Antihypertensive (14)
5
1.5
I: salads
Antiseptic (1, 2, 8)
6
1.8
Antidote, blood purifying (1, 8)
4
1.2
Fl
E: maceration and local application
Rheumatism (1, 8, 12, 14, 16, 22)
33
10.1
E: EO mixed with olive oil and local application
18
5.5
Rosmarinus officinalis L.
Rosemary
Eklil-al-jabalHasa-al-bānNada-al-bahr
FpLeSt
I: decoction with distilled water once a day
Antiseptic (2, 12, 14, 25)
16
4.9
Antifungal (12, 20, 25)
11
3.4
Hypoglycemic (2, 14, 20)
13
4.0
Stomachic (2, 12, 25)
12
3.7
Carminative (20, 25)
8
2.5
Antianemic (14)
7
2.1
Febrifuge (14, 20)
4
1.2
Constipation (2, 25)
6
1.8
Splenomegaly (20)
5
1.5
Emmenagogue (12, 20)
4
1.2
Cholagogue (2, 14)
5
1.5
Le
I: infusion 30 g/L of water, drinking one cup, 3 times a day until improvement
Liver diseases (13, 18)
5
1.5
Arteriosclerosis, cardiotonic (7, 13)
6
1.8
Antianemic (13)
3
0.9
Asthma (7)
3
0.9
E: macerated in alcohol and locally applied or leaves added to bath
Rheumatism (1, 22, 23)
28
8.6
E: EO diluted in alcohol and water and local application
Antiseptic (4,19, 21)
26
8.0
E: EO mixed with olive oil and applied locally to the affected areas; alcohol macerate decoction
Rheumatism (2, 12, 14)
31
9.5
Salvia fruticosa Miller.
Sage
Aiza’anKassiin‘OuaisséMaryamiyyé
FpLe
I: decoction
Stimulating memory (2, 3, 5, 12, 14)
8
2.5
Hypoglycemic (2, 5)
18
5.5
Rheumatism (3, 5, 12)
20
6.1
Influenza (3, 14)
14
4.3
Antihypertensive (5, 12, 14)
16
4.9
Gastralgia (2, 12)
12
3.7
Hepatitis (3, 5)
9
2.8
Nephropathy (5, 12)
8
2.5
Constipation (2, 14)
11
3.4
Carminative (3, 14)
13
4.0
I: 3 drops of EO added to one tablespoon of honey
Hypoglycemic (12, 14)
9
2.8
Cough, expectorant (2, 14, 15)
13
4.0
Spasmolytic (12)
5
1.5
Antimicrobial, antiseptic (1, 13, 15)
10
3.1
Febrifuge (13)
4
1.2
Rheumatism (1, 13, 15)
8
2.5
Le
I: decoction
Arthritis (13, 14, 15)
22
6.8
I: infusion
Stomachic (2, 9, 12, 15)
9
2.8
Aphrodisiac (12)
5
1.5
Febrifuge (15)
4
1.2
Hypoglycemic (2, 12)
7
2.1
Carminative (9, 15)
6
1.8
Hemostatic (9)
5
1.5
Asthma (2, 15)
5
1.5
Pharyngitis, laryngitis (2, 9)
6
1.8
Satureja cuneifolia Ten.
Wild savory
Eshabat-el- wasabZa’atar farisi
FpSt
I: infusion
Gastrointestinal disorders, (carminative, stomachic) (8, 25)
7
2.1
Spasmolytic (25)
5
1.5
Headache (26)
4
1.2
Satureja thymbra L.
Thyme-leaved savory
Za’atar khlatZa’atar bou khlaytZa’atar rumiZa’atar franjiZa’atar-al-hamirZa’atar
Fp
I: infusion, EO, and food
Antiseptic, antimicrobial, antifungal (2, 3, 12)
13
4.0
Cough (3, 12)
4
1.2
Blood purifying (2)
3
0.9
Anti-inflammatory (12, 14)
4
1.2
Nephropathy (3)
3
0.9
Le
I: infusion 50 g/L, 1 cup 3 times a day
Antidiarrheal (8, 9)
6
1.8
Cough (9)
4
1.2
Cardiotonic (8)
4
1.2
Paralysis (8)
3
0.9
Thymbra spicataL.
Wild thyme
Za’atar khlatZa’atar bou khlaytZa’atar
Fp
I: infusion, EO, and food
Antimicrobial, antifungal (2, 3, 20, 26)
14
4.3
Cough (3, 20, 26)
9
2.8
Arteriosclerosis, cardiotonic (2, 20)
8
2.5
Blood purifying (20, 26)
6
1.8
Insomnia (3)
5
1.5
Wp
E: gargling or mastication
Toothache (20)
5
1.5
I: decoction
Emmenagogue (20)
3
0.9
Hypoglycemic (20, 21)
4
1.2
Sterility (17, 21)
3
0.9
Oxytocic (21)
3
0.9
E: decoction
Ophthalmia (20, 22)
8
2.5
Vitex agnus-castus L.
Chaste tree
Felfel-al-rahebKaff Mariam
FlFtSe
I: infusion, 1 cup daily
Vermifuge (21)
5
1.5
Gastralgia (17)
4
1.2
Sedative (20)
4
1.2
Hypoglycemic (20, 21)
3
0.9
Anaphrodisiac (17)
3
0.9
I: decoction
Emmenagogue (20)
3
0.9
Hypoglycemic (20)
3
0.9
Oxytocic (17)
4
1.2
Sterility (17, 21)
4
1.2
E: decoction
Ophthalmia (20, 22)
8
2.5
Part used: Fp = flowering parts, Le = leaves, Fl = flowers, Wp = whole plant, St = stems, Ft = fruits, Se = seeds, and Dp = dried plant. Use: E = external use; I = internal use.
Numbers from 1 to 26 are abbreviations of the 25 districts of Lebanon and the governorate of Beirut (Beirut province is undivided): Akkar 1, Aley 2, Baabda 3, Baalbek 4, Batroun 5, Beirut 6, Bint Jbeil 7, Bcharre 8, Chouf 9, Hasbaya 10, Hermel 11, Jbeil 12, Jezzine 13, Keserwan 14, Koura 15, Marjeyoun 16, Metn 17, Miniyeh-Danniyeh 18, Nabatiye 19, Rachaya 20, Sidon (Saida) 21, Tripoli 22, Tyre (Sour) 23, West Bekaa 24, Zahle 25, and Zgharta 26.
The symbolsN and Fr are used to indicate the number and frequency of people mentioning the indication in a single plant from the total number of interviewees; that is, Fr = (N/total number of interviewees) × 100.
A
l
l
∗ Lamiaceae species cited and reported in this table are indigenous to Lebanon, except L. angustifolia that is imported and cultivated.The plants have been identified based on the “Nouvelle flore du Liban et de la Syrie” (Mouterde) [16] and the Med-Checklist (http://ww2.bgbm.org/mcl/). We followed the new phylogenetic classification APG II [17] in order to update the families cited in Mouterde. Voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon.


### 2.3. Essential Oil Extraction

The essential oils (EOs) were obtained by hydrodistillation performed for 3 h using a Clevenger-type apparatus according to the European Pharmacopoeia [18]. Yields are given in Table 4.


### 2.4. Essential Oils Analyses

#### 2.4.1. GC Analyses

Analytical gas chromatography was carried out on a Thermo Electron Corporation gas chromatograph fitted with a DB-5 MS capillary column (30 m × 0.25 mm) with 0.1µm film thickness or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm). Helium was the carrier gas (0.7 mL/min). The column temperature was initially set to 35°C before being gradually increased to 85°C at 5°C/min, held for 20 min at 85°C, raised to 300°C at 10°C/min, and finally held for 5 min at 300°C. Diluted 1 µL samples (1/100, v/v) were injected at 250°C manually and in the splitless mode. Flame ionisation detection (FID) was performed at 310°C.


#### 2.4.2. GC/MS Analyses

The GC/MS analyses were performed using an Agilent 6890 gas chromatograph coupled with 5975 Mass Detector. The 7683B autosampler injected 1µL of each oil sample. A fused silica capillary column DB-5 MS (30 m × 0.25 mm internal diameter, film thickener 0.1 µm) or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm) was used. Helium was the carrier gas (0.7 mL/min). The oven temperature program was identical to that described in Section 2.4.1. The mass spectra were recorded at 70 eV with an ion source temperature of 310°C and a transfer line heated to 320°C. The acquisition was recorded in full scan mode (50–400 amu).


#### 2.4.3. Identifications and Quantifications

Most constituents were identified by gas chromatography by comparing their retention indices (RI) with those from the literature [19, 20] or with those of authentic compounds obtained from Sigma-Aldrich (Lebanon). The retention indices were determined relatively to a homologous series ofn-alkanes (C8 to C24) analysed under the same operating conditions. Further identification was obtained by comparing their mass spectra on both columns with those provided in the NIST and Wiley 275 libraries, our homemade library constructed with pure compounds, and EOs of known composition or with mass spectra from the literature [19, 21]. The relative concentrations of the components were calculated based on the GC peak areas without correction; they are reported in Table 4.


### 2.5. Antimicrobial Activity

#### 2.5.1. Microorganisms

The antimicrobial activity of the essential oils was investigated against the Gram (−) bacterial strainEscherichia coli ATCC 25922, the Gram (+) bacterial strainStaphylococcus aureus ATCC 29213, the yeastCandida albicans ATCC 10231, and a clinical isolate of the dermatophyteTrichophyton rubrum SNB-TR [22].


#### 2.5.2. Microdilution Method

The antimicrobial activity of the EOs was measured using a broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [23–26]. The essential oils and their major components were diluted in DMSO and were tested at concentrations ranging from 512 to 16 μg/mL. The microplates were incubated at 37°C for 24 h for bacteria, 48 h for yeasts, and 5 days for dermatophytes. The minimal inhibitory concentrations (MIC) refer to the lowest concentrations preventing visible microbial growth (Table 5). Oxacillin and gentamicin (16—0.03 μg/mL) were used as reference antibiotics, while itraconazole (16—0.03 μg/mL) and fluconazole (64—0.125 μg/mL) were used as positive controls for the antifungal assays. The antimicrobial standards were purchased from Molekula, Dorset, UK, and the pure terpenes from Sigma-Aldrich, Lebanon.


## 2.1. Ethnomedical Field Survey and Ethnobotanical Data Collection

The research was carried out in different regions of Lebanon from the north to the south and from the coast to the mountains, including the anti-Lebanon mountain range and the steppe. A great variety of wild plant species according to different ecological conditions can therefore be found. The surveys were conducted in the cities and villages of the twenty-five districts (“aqdya” or “qadaa”) of the six governorates (“mohaafazah”) of Lebanon (Figure1).Figure 1
Studied area: the governorates and districts of Lebanon.Ethnobotanical and ethnomedicinal information was obtained between the years 2002 and 2008 from 325 interviewees from 223 villages covering all the districts of Lebanon. Most of the participants interviewed were herbalists (“Attarin” or “dabbous”), shepherds, farmers, folk healers, or older experienced people and midwives (“daye”) between 40 and 70 years old. The people interviewed declared that their knowledge about the traditional medicine was transmitted mainly orally from older generations. Interviewees were accompanied to the field individually where they would point out the herbs that have been using to cure the mentioned disease. This was also to confirm plant identification (vernacular names can be different in different regions of Lebanon) and obtain fresh samples for herbarium voucher. When the fertile part was not available, the plant was visited again at the appropriate time to obtain a fertile sample.The obtained information was cross-checked with that of other informants, and also, after a week, the interview was repeated with the same person. Only medical usages of plants given at least by three separate informants have been reported in this investigation. It was verified that each informant is able to recognize the mentioned plant species in the wild.The questionnaire form was based on the botanical and ethnopharmacognosic survey of traditional medicine plants, suggested by WHO [15]. The collected information included local names, used part(s) of the plant, folk medicinal uses and therapeutic properties, method of preparation, way of administration, doses, and duration of treatment. The results are recorded in a synoptic table (Table 2).


## 2.2. Plant Material

Plant material was collected in several locations throughout Lebanon and voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon. Specimens of the Lamiaceae species were collected as described in Table1.Table 1
Plant material collection information.
Plant name
Part used
Collection region
Collection date
Voucher number
Region
District
GPS Location
Altitude (m)
Coridothymus capitatus
Flowering tops
Anfeh
Koura
34°21′38.69′′N35°43′58.96′′E
8
August 2011
MNV191a
Lavandula angustifolia
Flowering tops
Qartaba
Mount Lebanon
34°05′39.18′′N35°50′38.99′′E
1170
May 2012
MNC121
Lavandula stoechas
Flowering tops
Adonis
Keserwan
33°58′05.91′′N35°36′35.20′′E
50
May 2012
MNV114
Mentha spicata
Flowering tops
Kfarzebian
Mount Lebanon
33°59′53.43′′N35°51′29.69′′E
2015
July 2012
MNV194
Satureja cuneifolia
Leaves
MNV173
Origanum syriacum
Flowering tops
Alita
Keserwan
34°05′29.72′′N35° 41′27.05′′E
620
August 2012
MNV188
Rosmarinus officinalis
Leaves
Shuwayfat
Mount Lebanon
34°48′32.43′′N33°48′32.43′′E
200
October 2011
MNV154
Salvia fruticosa
Leaves
Nahr Ibrahim
Mount Lebanon
34°04′24.34′′N35°39′19.03′′E
190
June 2012
MNV159
Satureja thymbra
Flowering tops
MNV173a
Thymbra spicata
Leaves
MNV191
Vitex agnus-castus
Flowering tops
Nahr Ibrahim
Mount Lebanon
34°03′42.70′′N35°38′44.52′′E
7
June 2012
MNV096Table 2
Traditional remedies from Lamiaceae plant species in Lebanon.
Scientific name
Common name
Vernacular names in Lebanon
Part used
Preparation
Traditional medicinal indication in Lebanon
N
Fr (%)
Coridothymus capitatus (L.) Reichenb. Fil
Conehead Thyme
Za’atar farisiZa’atar ‘assalZa’atar
Fp
I: infusion or decoction on an empty stomach, one cup in the morning
Gastrointestinal disorders (colics, gastritis, stomach aches, carminative) (5, 6, 9, 15)
16
4.9
Antidiarrheal (6, 15)
6
1.8
Antiemetic (5, 9)
5
1.5
Antihypertensive (6, 9)
6
1.8
Vermifuge (5, 6, 15)
4
1.2
Spasmolytic (15)
5
1.5
Acne (9)
4
1.2
Antiseptic (6, 9, 15)
9
2.8
I: cold infusion
Dermatosis (5, 15)
4
1.2
Le
I: infusion, 1 teaspoon in a cup of water, drinking 3 cups per day
Cough, pneumonia, expectorant (5, 6, 15)
8
2.5
Hypoglycemic (6, 15)
5
1.5
Stomachic (5, 6)
6
1.8
Febrifuge (6)
3
0.9
Lavandula stoechas L.
Spanish lavender
Astakhoudos KhuzamaShih
Fp
I: infusion, 1 or 2 cups per day
Antiseptic (2, 9, 12, 20, 22)
10
3.1
Gastrointestinal disorders (9, 12, 20)
7
2.1
Spasmolytic (12, 17, 22)
5
1.5
Rheumatism (2, 20)
6
1.8
Cardiotonic (9, 17, 22)
6
1.8
Lavandula angustifolia Mill. (c
u
l
t
i
v
a
t
e
d
∗)
Common lavender or English lavender
KhuzamaLawanda
FpLeSt
I: infusion, 2 cups per day
Hypoglycemic (6, 12, 14, 18, 20)
10
3.1
Antihypertensive (12, 18, 20)
9
2.8
Hepatitis (14, 20)
7
2.1
Antiseptic (6, 14, 18)
9
2.8
Dermatitis (6, 18, 20)
8
2.5
Migraine (12, 18)
3
0.9
Flu (14, 18)
4
1.2
Asthenia, stimulant (14, 20)
5
1.5
Stomachic, antispasmodic, carminative (6, 12, 14, 18)
11
3.4
Sedative (6, 12, 20)
4
1.2
Uricemia (12)
3
0.9
Diuretic (12, 18)
6
1.8
E: EO massage
Healing (14, 17)
8
2.5
Rheumatism (14, 17)
9
2.8
Lumbago (17)
4
1.2
Mentha spicata L. subsp. condensata (Briq.) Greuter & Burdet
Wild mint
Na’ana’a barri
Le
I: infusion
Digestive disorders (12, 17, 20, 24, 25)
12
3.7
Antimicrobial (12, 20, 25)
9
2.8
Gastritis (17, 24, 25)
5
1.5
Antiemetic (17, 24)
4
1.2
Arthritis (12, 20)
4
1.2
Origanum syriacum L.
Biblical-hyssop, Lebanese oregano, or Syrian oregano
Zouba’ Za’atar
Fp
I: decoction mixed with honey 2 cups per day; food mixtures
Antiseptic, antimicrobial (1, 8, 10, 11, 12, 13, 14, 26)
15
4.6
Vermifuge (8, 11, 14)
8
2.5
Pertussis (10, 12, 13)
6
1.8
Antihypertensive (1, 10, 14, 26)
10
3.1
Hypoglycemic (11, 12, 13)
7
2.1
Stomachic (1, 13, 14, 26)
9
2.8
Spasmolytic (8, 11, 12)
7
2.1
Antidiarrheal (11, 13, 14)
8
2.5
Rheumatism (1, 12, 26)
8
2.5
Asthma (1, 8)
7
2.1
Migraine (13, 14)
6
1.8
Appetizer (8, 26)
5
1.5
Stimulating memory (13)
6
1.8
Le
I: infusion 20 g/L; 250–500 mL/day
Cough, expectorant (2, 9)
6
1.8
Vermifuge (2)
5
1.5
Constipation (9)
3
0.9
I: infusion, drinking daily
Bronchitis (18, 22)
4
1.2
Hypoglycemia (22)
3
0.9
I: infusion, 1 teaspoon in a cup of water
Antihypertensive (12, 14)
6
1.8
Gastrointestinal disorders (8, 12, 14)
8
2.5
E: local application mixed with olive oil
Analgesic (2, 14)
6
1.8
Rheumatism (2, 12)
6
1.8
Antihypertensive (14)
5
1.5
I: salads
Antiseptic (1, 2, 8)
6
1.8
Antidote, blood purifying (1, 8)
4
1.2
Fl
E: maceration and local application
Rheumatism (1, 8, 12, 14, 16, 22)
33
10.1
E: EO mixed with olive oil and local application
18
5.5
Rosmarinus officinalis L.
Rosemary
Eklil-al-jabalHasa-al-bānNada-al-bahr
FpLeSt
I: decoction with distilled water once a day
Antiseptic (2, 12, 14, 25)
16
4.9
Antifungal (12, 20, 25)
11
3.4
Hypoglycemic (2, 14, 20)
13
4.0
Stomachic (2, 12, 25)
12
3.7
Carminative (20, 25)
8
2.5
Antianemic (14)
7
2.1
Febrifuge (14, 20)
4
1.2
Constipation (2, 25)
6
1.8
Splenomegaly (20)
5
1.5
Emmenagogue (12, 20)
4
1.2
Cholagogue (2, 14)
5
1.5
Le
I: infusion 30 g/L of water, drinking one cup, 3 times a day until improvement
Liver diseases (13, 18)
5
1.5
Arteriosclerosis, cardiotonic (7, 13)
6
1.8
Antianemic (13)
3
0.9
Asthma (7)
3
0.9
E: macerated in alcohol and locally applied or leaves added to bath
Rheumatism (1, 22, 23)
28
8.6
E: EO diluted in alcohol and water and local application
Antiseptic (4,19, 21)
26
8.0
E: EO mixed with olive oil and applied locally to the affected areas; alcohol macerate decoction
Rheumatism (2, 12, 14)
31
9.5
Salvia fruticosa Miller.
Sage
Aiza’anKassiin‘OuaisséMaryamiyyé
FpLe
I: decoction
Stimulating memory (2, 3, 5, 12, 14)
8
2.5
Hypoglycemic (2, 5)
18
5.5
Rheumatism (3, 5, 12)
20
6.1
Influenza (3, 14)
14
4.3
Antihypertensive (5, 12, 14)
16
4.9
Gastralgia (2, 12)
12
3.7
Hepatitis (3, 5)
9
2.8
Nephropathy (5, 12)
8
2.5
Constipation (2, 14)
11
3.4
Carminative (3, 14)
13
4.0
I: 3 drops of EO added to one tablespoon of honey
Hypoglycemic (12, 14)
9
2.8
Cough, expectorant (2, 14, 15)
13
4.0
Spasmolytic (12)
5
1.5
Antimicrobial, antiseptic (1, 13, 15)
10
3.1
Febrifuge (13)
4
1.2
Rheumatism (1, 13, 15)
8
2.5
Le
I: decoction
Arthritis (13, 14, 15)
22
6.8
I: infusion
Stomachic (2, 9, 12, 15)
9
2.8
Aphrodisiac (12)
5
1.5
Febrifuge (15)
4
1.2
Hypoglycemic (2, 12)
7
2.1
Carminative (9, 15)
6
1.8
Hemostatic (9)
5
1.5
Asthma (2, 15)
5
1.5
Pharyngitis, laryngitis (2, 9)
6
1.8
Satureja cuneifolia Ten.
Wild savory
Eshabat-el- wasabZa’atar farisi
FpSt
I: infusion
Gastrointestinal disorders, (carminative, stomachic) (8, 25)
7
2.1
Spasmolytic (25)
5
1.5
Headache (26)
4
1.2
Satureja thymbra L.
Thyme-leaved savory
Za’atar khlatZa’atar bou khlaytZa’atar rumiZa’atar franjiZa’atar-al-hamirZa’atar
Fp
I: infusion, EO, and food
Antiseptic, antimicrobial, antifungal (2, 3, 12)
13
4.0
Cough (3, 12)
4
1.2
Blood purifying (2)
3
0.9
Anti-inflammatory (12, 14)
4
1.2
Nephropathy (3)
3
0.9
Le
I: infusion 50 g/L, 1 cup 3 times a day
Antidiarrheal (8, 9)
6
1.8
Cough (9)
4
1.2
Cardiotonic (8)
4
1.2
Paralysis (8)
3
0.9
Thymbra spicataL.
Wild thyme
Za’atar khlatZa’atar bou khlaytZa’atar
Fp
I: infusion, EO, and food
Antimicrobial, antifungal (2, 3, 20, 26)
14
4.3
Cough (3, 20, 26)
9
2.8
Arteriosclerosis, cardiotonic (2, 20)
8
2.5
Blood purifying (20, 26)
6
1.8
Insomnia (3)
5
1.5
Wp
E: gargling or mastication
Toothache (20)
5
1.5
I: decoction
Emmenagogue (20)
3
0.9
Hypoglycemic (20, 21)
4
1.2
Sterility (17, 21)
3
0.9
Oxytocic (21)
3
0.9
E: decoction
Ophthalmia (20, 22)
8
2.5
Vitex agnus-castus L.
Chaste tree
Felfel-al-rahebKaff Mariam
FlFtSe
I: infusion, 1 cup daily
Vermifuge (21)
5
1.5
Gastralgia (17)
4
1.2
Sedative (20)
4
1.2
Hypoglycemic (20, 21)
3
0.9
Anaphrodisiac (17)
3
0.9
I: decoction
Emmenagogue (20)
3
0.9
Hypoglycemic (20)
3
0.9
Oxytocic (17)
4
1.2
Sterility (17, 21)
4
1.2
E: decoction
Ophthalmia (20, 22)
8
2.5
Part used: Fp = flowering parts, Le = leaves, Fl = flowers, Wp = whole plant, St = stems, Ft = fruits, Se = seeds, and Dp = dried plant. Use: E = external use; I = internal use.
Numbers from 1 to 26 are abbreviations of the 25 districts of Lebanon and the governorate of Beirut (Beirut province is undivided): Akkar 1, Aley 2, Baabda 3, Baalbek 4, Batroun 5, Beirut 6, Bint Jbeil 7, Bcharre 8, Chouf 9, Hasbaya 10, Hermel 11, Jbeil 12, Jezzine 13, Keserwan 14, Koura 15, Marjeyoun 16, Metn 17, Miniyeh-Danniyeh 18, Nabatiye 19, Rachaya 20, Sidon (Saida) 21, Tripoli 22, Tyre (Sour) 23, West Bekaa 24, Zahle 25, and Zgharta 26.
The symbolsN and Fr are used to indicate the number and frequency of people mentioning the indication in a single plant from the total number of interviewees; that is, Fr = (N/total number of interviewees) × 100.
A
l
l
∗ Lamiaceae species cited and reported in this table are indigenous to Lebanon, except L. angustifolia that is imported and cultivated.The plants have been identified based on the “Nouvelle flore du Liban et de la Syrie” (Mouterde) [16] and the Med-Checklist (http://ww2.bgbm.org/mcl/). We followed the new phylogenetic classification APG II [17] in order to update the families cited in Mouterde. Voucher specimens were deposited at the Herbarium of Botany of the U.S.E.K., Lebanon.


## 2.3. Essential Oil Extraction

The essential oils (EOs) were obtained by hydrodistillation performed for 3 h using a Clevenger-type apparatus according to the European Pharmacopoeia [18]. Yields are given in Table 4.


## 2.4. Essential Oils Analyses

### 2.4.1. GC Analyses

Analytical gas chromatography was carried out on a Thermo Electron Corporation gas chromatograph fitted with a DB-5 MS capillary column (30 m × 0.25 mm) with 0.1µm film thickness or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm). Helium was the carrier gas (0.7 mL/min). The column temperature was initially set to 35°C before being gradually increased to 85°C at 5°C/min, held for 20 min at 85°C, raised to 300°C at 10°C/min, and finally held for 5 min at 300°C. Diluted 1 µL samples (1/100, v/v) were injected at 250°C manually and in the splitless mode. Flame ionisation detection (FID) was performed at 310°C.


### 2.4.2. GC/MS Analyses

The GC/MS analyses were performed using an Agilent 6890 gas chromatograph coupled with 5975 Mass Detector. The 7683B autosampler injected 1µL of each oil sample. A fused silica capillary column DB-5 MS (30 m × 0.25 mm internal diameter, film thickener 0.1 µm) or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm) was used. Helium was the carrier gas (0.7 mL/min). The oven temperature program was identical to that described in Section 2.4.1. The mass spectra were recorded at 70 eV with an ion source temperature of 310°C and a transfer line heated to 320°C. The acquisition was recorded in full scan mode (50–400 amu).


### 2.4.3. Identifications and Quantifications

Most constituents were identified by gas chromatography by comparing their retention indices (RI) with those from the literature [19, 20] or with those of authentic compounds obtained from Sigma-Aldrich (Lebanon). The retention indices were determined relatively to a homologous series ofn-alkanes (C8 to C24) analysed under the same operating conditions. Further identification was obtained by comparing their mass spectra on both columns with those provided in the NIST and Wiley 275 libraries, our homemade library constructed with pure compounds, and EOs of known composition or with mass spectra from the literature [19, 21]. The relative concentrations of the components were calculated based on the GC peak areas without correction; they are reported in Table 4.


## 2.4.1. GC Analyses

Analytical gas chromatography was carried out on a Thermo Electron Corporation gas chromatograph fitted with a DB-5 MS capillary column (30 m × 0.25 mm) with 0.1µm film thickness or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm). Helium was the carrier gas (0.7 mL/min). The column temperature was initially set to 35°C before being gradually increased to 85°C at 5°C/min, held for 20 min at 85°C, raised to 300°C at 10°C/min, and finally held for 5 min at 300°C. Diluted 1 µL samples (1/100, v/v) were injected at 250°C manually and in the splitless mode. Flame ionisation detection (FID) was performed at 310°C.


## 2.4.2. GC/MS Analyses

The GC/MS analyses were performed using an Agilent 6890 gas chromatograph coupled with 5975 Mass Detector. The 7683B autosampler injected 1µL of each oil sample. A fused silica capillary column DB-5 MS (30 m × 0.25 mm internal diameter, film thickener 0.1 µm) or a fused silica HP Innowax polyethylene glycol capillary column (50 m × 0.20 mm, film thickness 0.20 µm) was used. Helium was the carrier gas (0.7 mL/min). The oven temperature program was identical to that described in Section 2.4.1. The mass spectra were recorded at 70 eV with an ion source temperature of 310°C and a transfer line heated to 320°C. The acquisition was recorded in full scan mode (50–400 amu).


## 2.4.3. Identifications and Quantifications

Most constituents were identified by gas chromatography by comparing their retention indices (RI) with those from the literature [19, 20] or with those of authentic compounds obtained from Sigma-Aldrich (Lebanon). The retention indices were determined relatively to a homologous series ofn-alkanes (C8 to C24) analysed under the same operating conditions. Further identification was obtained by comparing their mass spectra on both columns with those provided in the NIST and Wiley 275 libraries, our homemade library constructed with pure compounds, and EOs of known composition or with mass spectra from the literature [19, 21]. The relative concentrations of the components were calculated based on the GC peak areas without correction; they are reported in Table 4.


## 2.5. Antimicrobial Activity

### 2.5.1. Microorganisms

The antimicrobial activity of the essential oils was investigated against the Gram (−) bacterial strainEscherichia coli ATCC 25922, the Gram (+) bacterial strainStaphylococcus aureus ATCC 29213, the yeastCandida albicans ATCC 10231, and a clinical isolate of the dermatophyteTrichophyton rubrum SNB-TR [22].


### 2.5.2. Microdilution Method

The antimicrobial activity of the EOs was measured using a broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [23–26]. The essential oils and their major components were diluted in DMSO and were tested at concentrations ranging from 512 to 16 μg/mL. The microplates were incubated at 37°C for 24 h for bacteria, 48 h for yeasts, and 5 days for dermatophytes. The minimal inhibitory concentrations (MIC) refer to the lowest concentrations preventing visible microbial growth (Table 5). Oxacillin and gentamicin (16—0.03 μg/mL) were used as reference antibiotics, while itraconazole (16—0.03 μg/mL) and fluconazole (64—0.125 μg/mL) were used as positive controls for the antifungal assays. The antimicrobial standards were purchased from Molekula, Dorset, UK, and the pure terpenes from Sigma-Aldrich, Lebanon.


## 2.5.1. Microorganisms

The antimicrobial activity of the essential oils was investigated against the Gram (−) bacterial strainEscherichia coli ATCC 25922, the Gram (+) bacterial strainStaphylococcus aureus ATCC 29213, the yeastCandida albicans ATCC 10231, and a clinical isolate of the dermatophyteTrichophyton rubrum SNB-TR [22].


## 2.5.2. Microdilution Method

The antimicrobial activity of the EOs was measured using a broth microdilution method according to the Clinical and Laboratory Standards Institute (CLSI) guidelines [23–26]. The essential oils and their major components were diluted in DMSO and were tested at concentrations ranging from 512 to 16 μg/mL. The microplates were incubated at 37°C for 24 h for bacteria, 48 h for yeasts, and 5 days for dermatophytes. The minimal inhibitory concentrations (MIC) refer to the lowest concentrations preventing visible microbial growth (Table 5). Oxacillin and gentamicin (16—0.03 μg/mL) were used as reference antibiotics, while itraconazole (16—0.03 μg/mL) and fluconazole (64—0.125 μg/mL) were used as positive controls for the antifungal assays. The antimicrobial standards were purchased from Molekula, Dorset, UK, and the pure terpenes from Sigma-Aldrich, Lebanon.


## 3. Results and Discussion

### 3.1. Ethnopharmacological Data

This investigation showed that Lamiaceae species and especially the eleven ones reported in this study are still frequently used in Lebanon as herbal remedies (Table2).Origanum syriacum andSalvia fruticosa are the two most cited plants. It should be noted that the same vernacular name is sometimes used for different species. For example, the appellation “Za’atar” is used forSatureja thymbra,Thymbra spicata,Coridothymus capitatus, andOriganum syriacum.


### 3.2. Plant Parts Used

The plant parts used most frequently are the flowering tops and the leaves (34.6% each), followed by the stems (11.5%), flowers (7.7%), whole plant, fruits, and seeds (3.8% each) (Table3).Table 3
Most cited preparation and administration mode, plant parts, used and traditional medicinal indications.
Mode of administration
Nb
%
Internal use
23
71.8
External use
9
28.2
Preparation
Nb
%
Infusion
16
40.0
Decoction
7
17.5
EO application
7
17.5
Food
6
15.0
Maceration and local application
2
5.0
Gargle
1
2.5
Mastication
1
2.5
Plant parts used
Abbreviated
Nb
%
Flowering parts
Fp
9
34.6
Leaves
Le
9
34.6
Stems
St
3
11.5
Flowers
Fl
2
7.7
Whole plant
Wp
1
3.8
Fruits
Ft
1
3.8
Seeds
Se
1
3.8
Traditional medicinal indication
Nb
%
Gastrointestinal disorders (gastritis, spasmolytic, stomachic…)
13
12.4
Antimicrobial (antiseptic, antifungal, dermatoses)
12
11.4
Hypoglycemic
10
9.5
Rheumatism
9
8.6
Respiratory disorders (bronchitis, cough…)
8
7.6
Antihypertensive
6
5.7
Carminative
6
5.7
Vermifuge
4
3.8
Cardiotonic
4
3.8
Febrifuge
3
2.8
Flu/influenza
3
2.8
Constipation
3
2.8
Hepatitis
3
2.8
Nephropathy
3
2.8
Blood purifying
3
2.8
V
a
r
i
o
u
s
∗
15
14.3
Number of districts describing the use of each species
Nb
%
Coridothymus capitatus
4
15.4
Lavandula stoechas
6
23.1
Lavandula angustifolia
6
23.1
Mentha spicata
5
19.2
Origanum syriacum
13
50.0
Rosmarinus officinalis
15
57.7
Salvia fruticosa
9
34.6
Satureja cuneifolia
3
11.5
Satureja thymbra
6
23.1
Thymbra spicata
7
26.9
Vitex agnus-castus
4
15.4
Nb = number of times cited in Table1; % = percentage of each citation.
∗Indications cited less than three times are listed under various indications.Table 4
Composition of the essential oils of the eleven Lamiaceae species.
Coridothymus capitatus
Lavandula angustifolia
Lavandula stoechas
Mentha spicatasubsp. condensata
Origanum syriacum
Rosmarinus officinalis
Salvia fruticosa
Satureja cuneifolia
Satureja thymbra
Thymbra spicata
Vitex agnus-castus
Flowering tops EO
Flowering tops EO
Flowering tops EO
Flowering tops EO
Flowering tops EO
Leaves EO
Leaves EO
Leaves EO
Flowering tops EO
Leaves EO
Flowering tops EO
EOs yields (%)
1.3
2.3
0.9
0.8
1.3
0.6
2.4
2.1
2.5
4.1
0.3
R
i
a
R
i
b
Compound ID
I
d
e
n
t
i
f
i
c
a
t
i
o
n
c
929
1035
α-Thujene
R
i, MS, CoGC
0.5
0.2
t
t
1.0
0.1
t
0.8
1.3
1.5
0.1
938
1076
α-Pinene
R
i, MS, CoGC
0.3
0.7
2.2
0.2
0.5
5.4
2.6
0.3
1.2
0.5
7.1
953
1076
Camphene
R
i, MS, CoGC
0.2
0.5
0.6
0.1
0.1
1.7
0.9
0.1
0.4
0.1
t
973
1132
Sabinene
R
i, MS, CoGC
—
—
0.1
—
—
0.1
—
—
—
—
—
975
1312
1-Octene-3-ol
R
i, MS
0.3
0.3
—
—
0.5
—
0.2
0.1
0.2
0.2
—
980
1118
β-Pinene
R
i, MS, CoGC
0.1
0.4
0.3
—
0.1
1.9
1.5
0.1
0.4
0.1
4.4
993
1174
Myrcene
R
i, MS, CoGC
0.8
0.4
0.2
0.3
0.9
0.9
1.3
0.7
1.1
0.9
1.0
1005
1188
α-Phellandrene
R
i, MS, CoGC
0.2
0.1
t
0.1
0.2
—
0.1
—
0.6
0.1
0.6
1013
1159
δ-3-Carene
R
i, MS
0.1
0.3
—
—
0.1
t
—
t
—
0.1
—
1013
1188
α-Terpinene
R
i, MS, CoGC
1.0
—
0.2
t
1.6
0.4
0.1
1.4
1.0
1.2
0.1
1025
1280
p-Cymene
R
i, MS, CoGC
9.0
—
—
0.1
6.9
—
—
4.1
21.7
12.2
—
1030
1203
Limonene
R
i, MS, CoGC
—
—
—
1.0
—
—
—
—
—
—
—
1034
1213
Eucalyptol
R
i, MS, CoGC
—
8.6
9.5
—
—
21.5
57.3
—
—
—
20.5
1045
1269
cis-β-Ocimene
R
i, MS
t
2.3
—
—
t
—
—
t
—
t
—
1050
1253
trans-β-Ocimene
R
i, MS
t
0.3
t
t
0.1
t
t
0.1
0.1
t
0.9
1057
1255
γ-Terpinene
R
i, MS, CoGC
4.0
0.2
0.1
t
7.6
0.9
0.2
13.3
11.1
11.6
0.2
1058
1556
cis-Sabinene hydrate
R
i, MS
0.5
0.1
—
1.2
0.4
0.2
0.1
0.2
0.2
0.2
0.1
1086
1265
α-Terpinolene
R
i, MS
0.3
0.4
—
0.1
0.1
0.7
0.1
t
0.1
0.1
0.1
1079
1401
α-Fenchone
R
i, MS
—
—
36.2
—
—
—
—
—
—
—
—
1098
1553
Linalool
R
i, MS
0.7
45.8
—
—
0.2
—
—
0.1
0.9
0.1
0.3
1105
1430
α-Thujone
R
i, MS
—
—
—
—
—
—
1.0
—
—
—
—
1115
1449
β-Thujone
R
i, MS, CoGC
—
—
—
—
—
—
0.9
—
—
—
—
1116
1584
α-Fenchol
R
i, MS
—
—
0.7
—
—
—
—
—
—
—
—
1117
—
trans-p-Menth-2-en-1-ol
R
i, MS
0.1
—
—
—
—
0.2
—
—
t
t
—
1138
1475
Menthone
R
i, MS
—
—
—
5.1
—
—
—
—
—
—
—
1145
1532
Camphor
R
i, MS, CoGC
—
11.2
18.0
—
—
15.0
4.8
—
—
—
—
1167
1719
Borneol
R
i, MS, CoGC
0.8
7.5
0.1
—
0.1
7.9
2.1
t
0.3
0.1
—
1176
1611
Terpinen-4-ol
R
i, MS
1.0
5.8
0.2
1.7
0.2
1.0
0.5
0.2
0.2
0.3
0.3
1182
1864
p-Cymen-8-ol
R
i, MS
—
—
0.2
—
—
—
—
—
—
—
—
1189
1706
α-Terpineol
R
i, MS
0.2
—
0.3
0.2
0.1
3.1
4.2
0.2
0.1
0.1
0.7
1193
1648
Myrtenal
R
i, MS
—
—
0.2
—
—
—
—
—
—
—
—
1196
1804
Myrtenol
R
i, MS, CoGC
—
—
0.4
—
—
—
0.1
—
—
—
—
1215
1772
Citronellol
R
i, MS
—
—
—
—
—
—
—
—
—
—
t
1217
1725
Verbenone
R
i, MS
—
—
0.3
—
—
11.8
—
—
—
—
—
1217
1845
trans-Carveol
R
i, MS
—
t
—
—
—
0.1
t
—
—
—
—
1227
1698
Myrtenyl acetate
R
i, MS
—
—
1.0
t
—
0.2
—
—
—
—
—
1233
1662
Pulegone
R
i, MS, CoGC
—
—
—
78.7
—
—
—
—
—
—
—
1235
1857
Geraniol
R
i, MS, CoGC
0.1
—
—
—
—
0.1
—
—
—
—
0.1
1239
1607
Thymol methyl ether
R
i, MS
1.0
—
—
—
—
—
—
—
—
—
—
1245
1975
Carvacrol methyl ether
R
i, MS
0.7
—
—
—
0.1
—
—
1.4
0.1
t
—
1259
1665
Linalyl acetate
R
i, MS
—
4.6
—
—
—
—
—
—
—
—
—
1284
1597
Bornyl acetate
R
i, MS, CoGC
—
0.1
0.5
0.1
—
7.0
0.5
—
—
—
t
1293
2198
Thymol
R
i, MS, CoGC
29.3
—
—
—
74.4
—
0.4
—
44.5
0.4
—
1299
2239
Carvacrol
R
i, MS, CoGC
41.5
—
t
—
—
0.2
0.4
69.5
5.3
64.0
t
1333
1709
α-Terpinyl acetate
R
i, MS
—
—
—
—
—
—
2.2
—
—
—
1.2
1343
1748
Piperitone
R
i, MS
—
t
—
0.1
—
0.1
t
—
—
—
—
1353
2186
Eugenol
R
i, MS, CoGC
0.1
—
—
—
t
0.2
t
t
0.1
t
—
1377
1497
α-Copaene
R
i, MS,
—
—
1.1
—
—
—
—
t
—
—
—
1415
1612
β-Caryophyllene
R
i, MS, CoGC
1.8
0.6
0.2
2.8
1.1
6.3
8.3
—
1.2
0.5
6.6
1437
1628
Aromadendrene
R
i, MS
—
—
—
—
—
—
1.3
0.1
0.1
—
—
1452
1668
α-Humulene
R
i, MS
—
—
0.2
0.1
0.1
2.6
1.5
—
—
—
0.2
1455
1689
β-Farnesene
R
i, MS
0.1
—
—
0.3
—
—
—
—
—
—
16.1
1463
1661
Alloaromadendrene
R
i, MS
0.1
—
0.3
—
—
—
—
—
—
—
—
1464
1685
γ-Gurjunene
R
i, MS
t
—
0.2
—
—
—
0.1
t
—
—
1.2
1477
1726
Germacrene D
R
i, MS
—
0.4
—
0.2
t
—
—
0.4
—
—
—
1487
1679
α-Amorphene
R
i, MS
—
—
—
—
—
—
0.2
—
—
—
0.2
1491
1756
Bicyclogermacrene
R
i, MS
—
—
—
0.4
—
—
—
0.6
—
—
11.8
1508
1741
β-Bisabolene
R
i, MS
0.2
—
—
—
0.2
0.2
—
2.1
—
—
—
1526
1773
δ-Cadinene
R
i, MS
0.1
—
1.8
t
0.1
—
0.3
0.1
t
t
0.3
1553
2076
α-Copaene-8-ol
R
i, MS
—
—
4.7
—
—
—
—
—
—
—
—
1565
2057
Ledol
R
i, MS,
—
—
—
—
—
—
—
—
—
—
1.9
1577
2008
Caryophyllene oxide
R
i, MS, CoGC
0.8
0.3
1.4
0.6
0.3
0.7
0.8
—
2.0
0.8
—
1591
2104
Viridiflorol
R
i, MS,
—
—
3.6
—
—
—
1.1
—
—
—
0.3
1625
2088
1-epi-Cubenol
R
i, MS
—
—
1.8
—
—
—
—
—
—
—
—
1640
2188
τ-Cadinol
R
i, MS
—
0.2
—
—
0.2
—
—
—
—
—
—
1642
2209
τ-Muurolol
R
i, MS
—
—
1.8
—
t
—
—
t
—
—
—
1645
2145
Torreyol
R
i, MS
—
—
1.2
—
—
—
—
—
—
—
—
1649
2256
α-Cadinol
R
i, MS
—
—
—
—
—
—
—
—
—
—
0.3
1677
2256
Cadalene
R
i, MS
—
—
0.6
—
—
—
—
—
—
—
—
1688
2229
α-Bisabolol
R
i, MS, CoGC
—
0.1
—
—
t
—
—
0.1
—
—
0.2
1689
2276
Vulgarol B
R
i, MS
—
—
—
—
—
—
—
—
—
—
4.7
1948
—
Cembrene A
R
i, MS
—
—
—
—
—
—
—
—
—
—
2.8
1950
2603
Phytol
R
i, MS
—
—
—
0.1
—
0.1
—
0.1
—
—
—
1974
2408
Sclarene
R
i, MS
—
—
—
—
—
—
—
—
—
—
5.1
1987
2447
(E)-Geranyl linalool
R
i, MS
—
—
—
—
—
—
—
—
—
—
3.1
Monoterpene hydrocarbons
17.0
5.9
3.7
3.1
19.6
12.3
6.9
21.1
39.2
28.6
14.6
Oxygenated monoterpenes
75.8
83.9
67.6
85.9
75.6
68.4
74.6
71.5
51.7
65.2
23.1
Sesquiterpene hydrocarbons
2.3
1
4.4
3.8
1.5
9.1
11.7
3.3
1.3
0.5
36.4
Oxygenated sesquiterpenes
0.8
0.6
15.1
0.6
0.5
0.7
1.9
0.1
2.0
0.8
7.4
Diterpene hydrocarbons
—
—
—
—
—
—
—
—
—
—
7.9
Oxygenated diterpenes
—
—
—
0.1
—
0.1
—
0.1
—
—
3.1
Total identified
95.9
91.4
90.8
93.5
97.2
90.6
95.1
96.1
94.2
95.1
92.5
Notes: Bold numbers indicate the percentages higher than 2% to show main components; t = trace, less than 0.05%.
R
e
t
e
n
t
i
o
n
a index on a HP-5MS column. R
e
t
e
n
t
i
o
n
b index on an Innowax column; R
i
c retention index identical to bibliography; MS: identification based on comparison of mass spectra. Co-GC: retention time identical to authentic compounds.Table 5
Antimicrobial activity (MIC inµg/mL) of the Lamiaceae oils and there major compounds based on the microdilution method.
EOs and constituents
Microorganisms
S. aureus
E. coli
C. albicans
T. rubrum
ATCC 29213
ATCC 25922
ATCC 10231
SNB-TR1
Coridothymus capitatus
64
128
128
64
Lavandula angustifolia
512
>512
512
512
Lavandula stoechas
128
>512
512
256
Mentha spicata
>512
>512
>512
512
Origanum syriacum
128
256
128
64
Rosmarinus officinalis
512
>512
512
256
Salvia fruticosa
>512
>512
512
256
Satureja thymbra
128
256
128
128
Satureja cuneifolia
128
256
128
128
Thymbra spicata
128
256
128
64
Vitex agnus castus
512
>512
512
512
Thymol
128
n.t.
n.t.
32
Carvacrol
128
n.t.
n.t.
32
Thymol : carvacrol (1 : 1)
128
n.t.
n.t.
32
Camphor
>512
n.t.
n.t.
256
Eucalyptol
>512
n.t.
n.t.
256
Linalool
>512
n.t.
n.t.
256
γ-Terpinene
>512
n.t.
n.t.
512
p-Cymene
>512
n.t.
n.t.
64
α-Fenchone
>512
n.t.
n.t.
512
Oxacillin
0.5
n.t.
n.t.
n.t.
Gentamicin
n.t.
8
n.t.
n.t.
Itraconazole
n.t.
n.t.
4
<0.03
Fluconazole
n.t.
n.t.
16
2
Notes: n.t. = not tested.


### 3.3. Preparation and Administration

Most of the traditional remedies are administeredper os or internally (71.8%) although the majority of the EOs are applied externally (57.1%). The main modes of preparation are infusion (40.0%), decoction (17.5%), EO application (17.5%), and food consumption (15.0%) (Table 3). The contribution of the volatile organic compounds (VOCs) in all of these preparations is expected to be very important owing to the large amount of VOCs in Lamiaceae. The only exception is for decoctions because this process should eliminate most of the VOCs along with steam.


### 3.4. Traditional Medicinal Indications

Among the multiple medical usages of these plants, the eleven Lamiaceae species are mainly used to treat gastrointestinal disorders and microbial infections (Table3). Almost all of them are described to possess antiseptic, antimicrobial, or antifungal properties, and a significant proportion of the EOs has been reported to be applied locally to cure microbial infections (57.1%).


### 3.5. Number of Districts Describing the Use of Each Lamiaceae Species

The ethnopharmacological use ofRosmarinus officinalis andOriganum syriacum was mentioned by the largest number of districts (57.7 and 50%, resp.), while the medicinal use ofCoridothymus capitatus,Vitex agnus-castus, andSalvia fruticosa was localized in certain regions of Lebanon (Table 3).


### 3.6. Comparison with the Ethnopharmacological Uses in Other Mediterranean Countries

Despite the ancestral use of medicinal plants including essential oils in Lebanon, literature reports on Lebanese ethnomedicinal practices are scarce. Nevertheless, previous works have reported the medicinal uses of Lamiaceae species in the Mediterranean basin. Indeed, some of the plant species pointed out in our study are widely distributed and widely acknowledged by local people for medicinal purposes. In many cases, the uses reported in other countries are somewhat comparable to those found in Lebanon. For example, the cultivated lavenderLavandula angustifolia is used in Italy and Turkey as a sedative and antiseptic and to treat cold and rheumatism [27–29]. As for the wild lavender,Lavandula stoechas, it is used in Turkey and Spain for gastrointestinal and cardiovascular diseases [30–34]. Other examples includeCoridothymus capitatus andSalvia fruticosa used in Palestine and Israel to treat cold and gastrointestinal disorders [35–37],thymbra spicata used in Turkey for its cardiotonic and hypoglycemic properties, or to treat cough and arthrosclerosis [29, 30, 32],Vitex agnus-castus used in Palestine to treat eye inflammation [38], andMentha spicata andRosmarinus officinalis that are both used in Italy in the same way as in Lebanon as antiseptics and antimicrobials [27, 39].On the other hand, little is known on the plant species with restricted distribution areas, likeOriganum syriacum that is mainly used to treat cold symptoms in Turkey [40] and stomach pain in Jordan [41]. It is also the case ofSatureja cuneifolia andSatureja thymbra that are used in Turkey as immunotonic and cardiotonic and to treat cold and flu symptoms [32, 42].


### 3.7. Essential Oils Analyses

Since the VOCs seemed to be relevant in the context of the traditional medicinal use of Lebanese Lamiaceae, it was pertinent to study the chemical composition of their EOs. These are reported in Table4; the extraction yields and the relative proportions of the components are given.The yields (v/w, relative to dry weight material) obtained by hydrodistillation ranged from 0.3% fromV. agnus-castus flowering tops to 4.1% fromT. spicata leaves. GC and GC-MS analyses led to the identification of 75 components accounting for 90.6 to 97.2% of the total oils (Table 4). It was found that the EOs were essentially composed of oxygenated monoterpenes (51.7% to 85.9%), the only exception being that fromVitex agnus-castus which was mainly composed of sesquiterpene hydrocarbons (36.4%). Thymol and carvacrol were present in a high relative proportion in several EOs of these Lebanese chemotypes. Thymol was the major constituent ofOriganum syriacum (74.4%),Satureja thymbra (44.5%), andCoridothymus capitatus (29.3%) EOs, while carvacrol was highly abundant in the EOs ofSatureja cuneifolia (69.5%),Thymbra spicata (64.0%), andCoridothymus capitatus (29.3%). All of these species were also rich inp-cymene andγ-terpinene. The oils ofSalvia fruticosa,Rosmarinus officinalis, andVitex agnus-castus were essentially composed of eucalyptol representing 57.3%, 21.5%, and 20.5% of the total oils, respectively. Pulegone was the main component of the EO ofMentha spicata accounting for 78.7% of the oil. Wild and cultivated lavender EOs were significantly different;Lavandula stoechas (wild lavender) was mainly composed of α-fenchone (26.2%) while linalool (45.8%) was the major constituent ofLavandula angustifolia (cultivated lavender).


### 3.8. Comparison of the Main Components of the Lebanese Lamiaceae Species with Other Countries

The EOs ofVitex agnus-castus,Lavandula stoechas, andSalvia fruticosa have a very similar chemical composition compared to other countries [43–48].Lavandula angustifolia andCoridothymus capitatus Lebanese EOs are different than those from other regions. According to our study,Lavandula angustifolia EO contains a lower relative proportion of linalyl acetate [49] andCoridothymus capitatus is richer in thymol [50, 51]. The chemical composition of the EO ofRosmarinus officinalis is similar to that reported in Greece [52] but is different from the ones reported in Turkey and Tunisia where the main component of the Lebanese EO, eucalyptol, is absent [53, 54]. Both thymol and carvacrol chemotypes have been previously reported for our thymol-rich EOs likeSatureja thymbra [55, 56] andOriganum syriacum [57] or those in which carvacrol is the main constituent such asThymbra spicata [55, 58] andSatureja cuneifolia [59, 60]. Likewise,Mentha spicata oil reported in our study belongs to the pulegone chemotype, while a carvone chemotype has also been described in other regions [61, 62].


### 3.9. Antimicrobial Activity

The minimum inhibitory concentrations (MICs) of the Lamiaceae essential oils are presented in Table5. An oil was considered active if the minimal inhibitory concentration was 128 µg/mL or below [63]. The clinical isolateT. rubrum SNB-TR1 was the most sensitive, followed by the Gram (−) bacteriumS. aureusand the yeastC. albicans, whereas the Gram (+) bacteriumE. coli was more resistant. The oil ofCoridothymus capitatus was the only EO to possess a significant antibacterial activity againstE. coli with a MIC value of 128 µg/mL. This EO is rich in both thymol and carvacrol (29.3 and 41.5%, resp.). Overall, plants EOs with high relative amounts of thymol and/or carvacrol were the most active againstS. aureus,T. rubrum, andC. albicans with MIC values in the range of 64–128 µg/mL.To confirm the origin of the observed antimicrobial activity, the major constituents were tested against the two microorganisms that showed the greatest sensitivity,S. aureus andT. rubrum. Indeed, among the tested terpenes, only thymol and carvacrol showed significant antibacterial activity againstS. aureus (MIC 128 µg/mL). AgainstT. rubrum, these two compounds were also very active (MIC 32 µg/mL), followed byp-cymene (MIC 64 µg/mL). The antimicrobial potential of a combination of thymol and carvacrol in equal proportions was also measured but no synergistic effect was detected. The MIC of the combination of these two compounds was identical to that of each separate compound. The other important constituents, that is, camphor, eucalyptol, linalool, γ-terpinene, and α-fenchone, did not show any significant antimicrobial activity (Table 5).It has been previously reported that essential oils ofOriganum andThymus species contain mainly phenolic monoterpenes such as carvacrol and thymol and their activities are often attributed to these compounds [64–68].Our data confirm that these plants or their EOs could indeed be used in local applications for treating mycoses and demonstrate that combinations of thymol and carvacrol are not needed to account for the antifungal property of an EO.


### 3.10. Correlation Ethnopharmacology: Antimicrobial Activity

Ten species out of the eleven most cited Lamiaceae are used in the Lebanese traditional medicine as antiseptic or antimicrobial agents. Some are even cited specifically as antifungals (3 out of 11). Our results corroborate the antimicrobial indications forCoridothymus capitatus,Origanum syriacum,Lavandula stoechas,Satureja thymbra, andThymbra spicata, indicating that the use of these plant species is most likely linked to the antimicrobial potential of their VOCs. For example, the flowering parts ofC. capitatus are used as antiseptic and to treat dermatosis, and our results showed that the EO of the flowering tops can be considered active on all strains tested. The flowering parts ofO. syriacum,S. thymbra, andT. spicata are also used in Lebanon as antiseptic and antimicrobial agents and their EOs proved to be notably active againstS. aureus,C. albicans, andT. rubrum (Table 5).


## 3.1. Ethnopharmacological Data

This investigation showed that Lamiaceae species and especially the eleven ones reported in this study are still frequently used in Lebanon as herbal remedies (Table2).Origanum syriacum andSalvia fruticosa are the two most cited plants. It should be noted that the same vernacular name is sometimes used for different species. For example, the appellation “Za’atar” is used forSatureja thymbra,Thymbra spicata,Coridothymus capitatus, andOriganum syriacum.


## 3.2. Plant Parts Used

The plant parts used most frequently are the flowering tops and the leaves (34.6% each), followed by the stems (11.5%), flowers (7.7%), whole plant, fruits, and seeds (3.8% each) (Table3).Table 3
Most cited preparation and administration mode, plant parts, used and traditional medicinal indications.
Mode of administration
Nb
%
Internal use
23
71.8
External use
9
28.2
Preparation
Nb
%
Infusion
16
40.0
Decoction
7
17.5
EO application
7
17.5
Food
6
15.0
Maceration and local application
2
5.0
Gargle
1
2.5
Mastication
1
2.5
Plant parts used
Abbreviated
Nb
%
Flowering parts
Fp
9
34.6
Leaves
Le
9
34.6
Stems
St
3
11.5
Flowers
Fl
2
7.7
Whole plant
Wp
1
3.8
Fruits
Ft
1
3.8
Seeds
Se
1
3.8
Traditional medicinal indication
Nb
%
Gastrointestinal disorders (gastritis, spasmolytic, stomachic…)
13
12.4
Antimicrobial (antiseptic, antifungal, dermatoses)
12
11.4
Hypoglycemic
10
9.5
Rheumatism
9
8.6
Respiratory disorders (bronchitis, cough…)
8
7.6
Antihypertensive
6
5.7
Carminative
6
5.7
Vermifuge
4
3.8
Cardiotonic
4
3.8
Febrifuge
3
2.8
Flu/influenza
3
2.8
Constipation
3
2.8
Hepatitis
3
2.8
Nephropathy
3
2.8
Blood purifying
3
2.8
V
a
r
i
o
u
s
∗
15
14.3
Number of districts describing the use of each species
Nb
%
Coridothymus capitatus
4
15.4
Lavandula stoechas
6
23.1
Lavandula angustifolia
6
23.1
Mentha spicata
5
19.2
Origanum syriacum
13
50.0
Rosmarinus officinalis
15
57.7
Salvia fruticosa
9
34.6
Satureja cuneifolia
3
11.5
Satureja thymbra
6
23.1
Thymbra spicata
7
26.9
Vitex agnus-castus
4
15.4
Nb = number of times cited in Table1; % = percentage of each citation.
∗Indications cited less than three times are listed under various indications.Table 4
Composition of the essential oils of the eleven Lamiaceae species.
Coridothymus capitatus
Lavandula angustifolia
Lavandula stoechas
Mentha spicatasubsp. condensata
Origanum syriacum
Rosmarinus officinalis
Salvia fruticosa
Satureja cuneifolia
Satureja thymbra
Thymbra spicata
Vitex agnus-castus
Flowering tops EO
Flowering tops EO
Flowering tops EO
Flowering tops EO
Flowering tops EO
Leaves EO
Leaves EO
Leaves EO
Flowering tops EO
Leaves EO
Flowering tops EO
EOs yields (%)
1.3
2.3
0.9
0.8
1.3
0.6
2.4
2.1
2.5
4.1
0.3
R
i
a
R
i
b
Compound ID
I
d
e
n
t
i
f
i
c
a
t
i
o
n
c
929
1035
α-Thujene
R
i, MS, CoGC
0.5
0.2
t
t
1.0
0.1
t
0.8
1.3
1.5
0.1
938
1076
α-Pinene
R
i, MS, CoGC
0.3
0.7
2.2
0.2
0.5
5.4
2.6
0.3
1.2
0.5
7.1
953
1076
Camphene
R
i, MS, CoGC
0.2
0.5
0.6
0.1
0.1
1.7
0.9
0.1
0.4
0.1
t
973
1132
Sabinene
R
i, MS, CoGC
—
—
0.1
—
—
0.1
—
—
—
—
—
975
1312
1-Octene-3-ol
R
i, MS
0.3
0.3
—
—
0.5
—
0.2
0.1
0.2
0.2
—
980
1118
β-Pinene
R
i, MS, CoGC
0.1
0.4
0.3
—
0.1
1.9
1.5
0.1
0.4
0.1
4.4
993
1174
Myrcene
R
i, MS, CoGC
0.8
0.4
0.2
0.3
0.9
0.9
1.3
0.7
1.1
0.9
1.0
1005
1188
α-Phellandrene
R
i, MS, CoGC
0.2
0.1
t
0.1
0.2
—
0.1
—
0.6
0.1
0.6
1013
1159
δ-3-Carene
R
i, MS
0.1
0.3
—
—
0.1
t
—
t
—
0.1
—
1013
1188
α-Terpinene
R
i, MS, CoGC
1.0
—
0.2
t
1.6
0.4
0.1
1.4
1.0
1.2
0.1
1025
1280
p-Cymene
R
i, MS, CoGC
9.0
—
—
0.1
6.9
—
—
4.1
21.7
12.2
—
1030
1203
Limonene
R
i, MS, CoGC
—
—
—
1.0
—
—
—
—
—
—
—
1034
1213
Eucalyptol
R
i, MS, CoGC
—
8.6
9.5
—
—
21.5
57.3
—
—
—
20.5
1045
1269
cis-β-Ocimene
R
i, MS
t
2.3
—
—
t
—
—
t
—
t
—
1050
1253
trans-β-Ocimene
R
i, MS
t
0.3
t
t
0.1
t
t
0.1
0.1
t
0.9
1057
1255
γ-Terpinene
R
i, MS, CoGC
4.0
0.2
0.1
t
7.6
0.9
0.2
13.3
11.1
11.6
0.2
1058
1556
cis-Sabinene hydrate
R
i, MS
0.5
0.1
—
1.2
0.4
0.2
0.1
0.2
0.2
0.2
0.1
1086
1265
α-Terpinolene
R
i, MS
0.3
0.4
—
0.1
0.1
0.7
0.1
t
0.1
0.1
0.1
1079
1401
α-Fenchone
R
i, MS
—
—
36.2
—
—
—
—
—
—
—
—
1098
1553
Linalool
R
i, MS
0.7
45.8
—
—
0.2
—
—
0.1
0.9
0.1
0.3
1105
1430
α-Thujone
R
i, MS
—
—
—
—
—
—
1.0
—
—
—
—
1115
1449
β-Thujone
R
i, MS, CoGC
—
—
—
—
—
—
0.9
—
—
—
—
1116
1584
α-Fenchol
R
i, MS
—
—
0.7
—
—
—
—
—
—
—
—
1117
—
trans-p-Menth-2-en-1-ol
R
i, MS
0.1
—
—
—
—
0.2
—
—
t
t
—
1138
1475
Menthone
R
i, MS
—
—
—
5.1
—
—
—
—
—
—
—
1145
1532
Camphor
R
i, MS, CoGC
—
11.2
18.0
—
—
15.0
4.8
—
—
—
—
1167
1719
Borneol
R
i, MS, CoGC
0.8
7.5
0.1
—
0.1
7.9
2.1
t
0.3
0.1
—
1176
1611
Terpinen-4-ol
R
i, MS
1.0
5.8
0.2
1.7
0.2
1.0
0.5
0.2
0.2
0.3
0.3
1182
1864
p-Cymen-8-ol
R
i, MS
—
—
0.2
—
—
—
—
—
—
—
—
1189
1706
α-Terpineol
R
i, MS
0.2
—
0.3
0.2
0.1
3.1
4.2
0.2
0.1
0.1
0.7
1193
1648
Myrtenal
R
i, MS
—
—
0.2
—
—
—
—
—
—
—
—
1196
1804
Myrtenol
R
i, MS, CoGC
—
—
0.4
—
—
—
0.1
—
—
—
—
1215
1772
Citronellol
R
i, MS
—
—
—
—
—
—
—
—
—
—
t
1217
1725
Verbenone
R
i, MS
—
—
0.3
—
—
11.8
—
—
—
—
—
1217
1845
trans-Carveol
R
i, MS
—
t
—
—
—
0.1
t
—
—
—
—
1227
1698
Myrtenyl acetate
R
i, MS
—
—
1.0
t
—
0.2
—
—
—
—
—
1233
1662
Pulegone
R
i, MS, CoGC
—
—
—
78.7
—
—
—
—
—
—
—
1235
1857
Geraniol
R
i, MS, CoGC
0.1
—
—
—
—
0.1
—
—
—
—
0.1
1239
1607
Thymol methyl ether
R
i, MS
1.0
—
—
—
—
—
—
—
—
—
—
1245
1975
Carvacrol methyl ether
R
i, MS
0.7
—
—
—
0.1
—
—
1.4
0.1
t
—
1259
1665
Linalyl acetate
R
i, MS
—
4.6
—
—
—
—
—
—
—
—
—
1284
1597
Bornyl acetate
R
i, MS, CoGC
—
0.1
0.5
0.1
—
7.0
0.5
—
—
—
t
1293
2198
Thymol
R
i, MS, CoGC
29.3
—
—
—
74.4
—
0.4
—
44.5
0.4
—
1299
2239
Carvacrol
R
i, MS, CoGC
41.5
—
t
—
—
0.2
0.4
69.5
5.3
64.0
t
1333
1709
α-Terpinyl acetate
R
i, MS
—
—
—
—
—
—
2.2
—
—
—
1.2
1343
1748
Piperitone
R
i, MS
—
t
—
0.1
—
0.1
t
—
—
—
—
1353
2186
Eugenol
R
i, MS, CoGC
0.1
—
—
—
t
0.2
t
t
0.1
t
—
1377
1497
α-Copaene
R
i, MS,
—
—
1.1
—
—
—
—
t
—
—
—
1415
1612
β-Caryophyllene
R
i, MS, CoGC
1.8
0.6
0.2
2.8
1.1
6.3
8.3
—
1.2
0.5
6.6
1437
1628
Aromadendrene
R
i, MS
—
—
—
—
—
—
1.3
0.1
0.1
—
—
1452
1668
α-Humulene
R
i, MS
—
—
0.2
0.1
0.1
2.6
1.5
—
—
—
0.2
1455
1689
β-Farnesene
R
i, MS
0.1
—
—
0.3
—
—
—
—
—
—
16.1
1463
1661
Alloaromadendrene
R
i, MS
0.1
—
0.3
—
—
—
—
—
—
—
—
1464
1685
γ-Gurjunene
R
i, MS
t
—
0.2
—
—
—
0.1
t
—
—
1.2
1477
1726
Germacrene D
R
i, MS
—
0.4
—
0.2
t
—
—
0.4
—
—
—
1487
1679
α-Amorphene
R
i, MS
—
—
—
—
—
—
0.2
—
—
—
0.2
1491
1756
Bicyclogermacrene
R
i, MS
—
—
—
0.4
—
—
—
0.6
—
—
11.8
1508
1741
β-Bisabolene
R
i, MS
0.2
—
—
—
0.2
0.2
—
2.1
—
—
—
1526
1773
δ-Cadinene
R
i, MS
0.1
—
1.8
t
0.1
—
0.3
0.1
t
t
0.3
1553
2076
α-Copaene-8-ol
R
i, MS
—
—
4.7
—
—
—
—
—
—
—
—
1565
2057
Ledol
R
i, MS,
—
—
—
—
—
—
—
—
—
—
1.9
1577
2008
Caryophyllene oxide
R
i, MS, CoGC
0.8
0.3
1.4
0.6
0.3
0.7
0.8
—
2.0
0.8
—
1591
2104
Viridiflorol
R
i, MS,
—
—
3.6
—
—
—
1.1
—
—
—
0.3
1625
2088
1-epi-Cubenol
R
i, MS
—
—
1.8
—
—
—
—
—
—
—
—
1640
2188
τ-Cadinol
R
i, MS
—
0.2
—
—
0.2
—
—
—
—
—
—
1642
2209
τ-Muurolol
R
i, MS
—
—
1.8
—
t
—
—
t
—
—
—
1645
2145
Torreyol
R
i, MS
—
—
1.2
—
—
—
—
—
—
—
—
1649
2256
α-Cadinol
R
i, MS
—
—
—
—
—
—
—
—
—
—
0.3
1677
2256
Cadalene
R
i, MS
—
—
0.6
—
—
—
—
—
—
—
—
1688
2229
α-Bisabolol
R
i, MS, CoGC
—
0.1
—
—
t
—
—
0.1
—
—
0.2
1689
2276
Vulgarol B
R
i, MS
—
—
—
—
—
—
—
—
—
—
4.7
1948
—
Cembrene A
R
i, MS
—
—
—
—
—
—
—
—
—
—
2.8
1950
2603
Phytol
R
i, MS
—
—
—
0.1
—
0.1
—
0.1
—
—
—
1974
2408
Sclarene
R
i, MS
—
—
—
—
—
—
—
—
—
—
5.1
1987
2447
(E)-Geranyl linalool
R
i, MS
—
—
—
—
—
—
—
—
—
—
3.1
Monoterpene hydrocarbons
17.0
5.9
3.7
3.1
19.6
12.3
6.9
21.1
39.2
28.6
14.6
Oxygenated monoterpenes
75.8
83.9
67.6
85.9
75.6
68.4
74.6
71.5
51.7
65.2
23.1
Sesquiterpene hydrocarbons
2.3
1
4.4
3.8
1.5
9.1
11.7
3.3
1.3
0.5
36.4
Oxygenated sesquiterpenes
0.8
0.6
15.1
0.6
0.5
0.7
1.9
0.1
2.0
0.8
7.4
Diterpene hydrocarbons
—
—
—
—
—
—
—
—
—
—
7.9
Oxygenated diterpenes
—
—
—
0.1
—
0.1
—
0.1
—
—
3.1
Total identified
95.9
91.4
90.8
93.5
97.2
90.6
95.1
96.1
94.2
95.1
92.5
Notes: Bold numbers indicate the percentages higher than 2% to show main components; t = trace, less than 0.05%.
R
e
t
e
n
t
i
o
n
a index on a HP-5MS column. R
e
t
e
n
t
i
o
n
b index on an Innowax column; R
i
c retention index identical to bibliography; MS: identification based on comparison of mass spectra. Co-GC: retention time identical to authentic compounds.Table 5
Antimicrobial activity (MIC inµg/mL) of the Lamiaceae oils and there major compounds based on the microdilution method.
EOs and constituents
Microorganisms
S. aureus
E. coli
C. albicans
T. rubrum
ATCC 29213
ATCC 25922
ATCC 10231
SNB-TR1
Coridothymus capitatus
64
128
128
64
Lavandula angustifolia
512
>512
512
512
Lavandula stoechas
128
>512
512
256
Mentha spicata
>512
>512
>512
512
Origanum syriacum
128
256
128
64
Rosmarinus officinalis
512
>512
512
256
Salvia fruticosa
>512
>512
512
256
Satureja thymbra
128
256
128
128
Satureja cuneifolia
128
256
128
128
Thymbra spicata
128
256
128
64
Vitex agnus castus
512
>512
512
512
Thymol
128
n.t.
n.t.
32
Carvacrol
128
n.t.
n.t.
32
Thymol : carvacrol (1 : 1)
128
n.t.
n.t.
32
Camphor
>512
n.t.
n.t.
256
Eucalyptol
>512
n.t.
n.t.
256
Linalool
>512
n.t.
n.t.
256
γ-Terpinene
>512
n.t.
n.t.
512
p-Cymene
>512
n.t.
n.t.
64
α-Fenchone
>512
n.t.
n.t.
512
Oxacillin
0.5
n.t.
n.t.
n.t.
Gentamicin
n.t.
8
n.t.
n.t.
Itraconazole
n.t.
n.t.
4
<0.03
Fluconazole
n.t.
n.t.
16
2
Notes: n.t. = not tested.


## 3.3. Preparation and Administration

Most of the traditional remedies are administeredper os or internally (71.8%) although the majority of the EOs are applied externally (57.1%). The main modes of preparation are infusion (40.0%), decoction (17.5%), EO application (17.5%), and food consumption (15.0%) (Table 3). The contribution of the volatile organic compounds (VOCs) in all of these preparations is expected to be very important owing to the large amount of VOCs in Lamiaceae. The only exception is for decoctions because this process should eliminate most of the VOCs along with steam.


## 3.4. Traditional Medicinal Indications

Among the multiple medical usages of these plants, the eleven Lamiaceae species are mainly used to treat gastrointestinal disorders and microbial infections (Table3). Almost all of them are described to possess antiseptic, antimicrobial, or antifungal properties, and a significant proportion of the EOs has been reported to be applied locally to cure microbial infections (57.1%).


## 3.5. Number of Districts Describing the Use of Each Lamiaceae Species

The ethnopharmacological use ofRosmarinus officinalis andOriganum syriacum was mentioned by the largest number of districts (57.7 and 50%, resp.), while the medicinal use ofCoridothymus capitatus,Vitex agnus-castus, andSalvia fruticosa was localized in certain regions of Lebanon (Table 3).


## 3.6. Comparison with the Ethnopharmacological Uses in Other Mediterranean Countries

Despite the ancestral use of medicinal plants including essential oils in Lebanon, literature reports on Lebanese ethnomedicinal practices are scarce. Nevertheless, previous works have reported the medicinal uses of Lamiaceae species in the Mediterranean basin. Indeed, some of the plant species pointed out in our study are widely distributed and widely acknowledged by local people for medicinal purposes. In many cases, the uses reported in other countries are somewhat comparable to those found in Lebanon. For example, the cultivated lavenderLavandula angustifolia is used in Italy and Turkey as a sedative and antiseptic and to treat cold and rheumatism [27–29]. As for the wild lavender,Lavandula stoechas, it is used in Turkey and Spain for gastrointestinal and cardiovascular diseases [30–34]. Other examples includeCoridothymus capitatus andSalvia fruticosa used in Palestine and Israel to treat cold and gastrointestinal disorders [35–37],thymbra spicata used in Turkey for its cardiotonic and hypoglycemic properties, or to treat cough and arthrosclerosis [29, 30, 32],Vitex agnus-castus used in Palestine to treat eye inflammation [38], andMentha spicata andRosmarinus officinalis that are both used in Italy in the same way as in Lebanon as antiseptics and antimicrobials [27, 39].On the other hand, little is known on the plant species with restricted distribution areas, likeOriganum syriacum that is mainly used to treat cold symptoms in Turkey [40] and stomach pain in Jordan [41]. It is also the case ofSatureja cuneifolia andSatureja thymbra that are used in Turkey as immunotonic and cardiotonic and to treat cold and flu symptoms [32, 42].


## 3.7. Essential Oils Analyses

Since the VOCs seemed to be relevant in the context of the traditional medicinal use of Lebanese Lamiaceae, it was pertinent to study the chemical composition of their EOs. These are reported in Table4; the extraction yields and the relative proportions of the components are given.The yields (v/w, relative to dry weight material) obtained by hydrodistillation ranged from 0.3% fromV. agnus-castus flowering tops to 4.1% fromT. spicata leaves. GC and GC-MS analyses led to the identification of 75 components accounting for 90.6 to 97.2% of the total oils (Table 4). It was found that the EOs were essentially composed of oxygenated monoterpenes (51.7% to 85.9%), the only exception being that fromVitex agnus-castus which was mainly composed of sesquiterpene hydrocarbons (36.4%). Thymol and carvacrol were present in a high relative proportion in several EOs of these Lebanese chemotypes. Thymol was the major constituent ofOriganum syriacum (74.4%),Satureja thymbra (44.5%), andCoridothymus capitatus (29.3%) EOs, while carvacrol was highly abundant in the EOs ofSatureja cuneifolia (69.5%),Thymbra spicata (64.0%), andCoridothymus capitatus (29.3%). All of these species were also rich inp-cymene andγ-terpinene. The oils ofSalvia fruticosa,Rosmarinus officinalis, andVitex agnus-castus were essentially composed of eucalyptol representing 57.3%, 21.5%, and 20.5% of the total oils, respectively. Pulegone was the main component of the EO ofMentha spicata accounting for 78.7% of the oil. Wild and cultivated lavender EOs were significantly different;Lavandula stoechas (wild lavender) was mainly composed of α-fenchone (26.2%) while linalool (45.8%) was the major constituent ofLavandula angustifolia (cultivated lavender).


## 3.8. Comparison of the Main Components of the Lebanese Lamiaceae Species with Other Countries

The EOs ofVitex agnus-castus,Lavandula stoechas, andSalvia fruticosa have a very similar chemical composition compared to other countries [43–48].Lavandula angustifolia andCoridothymus capitatus Lebanese EOs are different than those from other regions. According to our study,Lavandula angustifolia EO contains a lower relative proportion of linalyl acetate [49] andCoridothymus capitatus is richer in thymol [50, 51]. The chemical composition of the EO ofRosmarinus officinalis is similar to that reported in Greece [52] but is different from the ones reported in Turkey and Tunisia where the main component of the Lebanese EO, eucalyptol, is absent [53, 54]. Both thymol and carvacrol chemotypes have been previously reported for our thymol-rich EOs likeSatureja thymbra [55, 56] andOriganum syriacum [57] or those in which carvacrol is the main constituent such asThymbra spicata [55, 58] andSatureja cuneifolia [59, 60]. Likewise,Mentha spicata oil reported in our study belongs to the pulegone chemotype, while a carvone chemotype has also been described in other regions [61, 62].


## 3.9. Antimicrobial Activity

The minimum inhibitory concentrations (MICs) of the Lamiaceae essential oils are presented in Table5. An oil was considered active if the minimal inhibitory concentration was 128 µg/mL or below [63]. The clinical isolateT. rubrum SNB-TR1 was the most sensitive, followed by the Gram (−) bacteriumS. aureusand the yeastC. albicans, whereas the Gram (+) bacteriumE. coli was more resistant. The oil ofCoridothymus capitatus was the only EO to possess a significant antibacterial activity againstE. coli with a MIC value of 128 µg/mL. This EO is rich in both thymol and carvacrol (29.3 and 41.5%, resp.). Overall, plants EOs with high relative amounts of thymol and/or carvacrol were the most active againstS. aureus,T. rubrum, andC. albicans with MIC values in the range of 64–128 µg/mL.To confirm the origin of the observed antimicrobial activity, the major constituents were tested against the two microorganisms that showed the greatest sensitivity,S. aureus andT. rubrum. Indeed, among the tested terpenes, only thymol and carvacrol showed significant antibacterial activity againstS. aureus (MIC 128 µg/mL). AgainstT. rubrum, these two compounds were also very active (MIC 32 µg/mL), followed byp-cymene (MIC 64 µg/mL). The antimicrobial potential of a combination of thymol and carvacrol in equal proportions was also measured but no synergistic effect was detected. The MIC of the combination of these two compounds was identical to that of each separate compound. The other important constituents, that is, camphor, eucalyptol, linalool, γ-terpinene, and α-fenchone, did not show any significant antimicrobial activity (Table 5).It has been previously reported that essential oils ofOriganum andThymus species contain mainly phenolic monoterpenes such as carvacrol and thymol and their activities are often attributed to these compounds [64–68].Our data confirm that these plants or their EOs could indeed be used in local applications for treating mycoses and demonstrate that combinations of thymol and carvacrol are not needed to account for the antifungal property of an EO.


## 3.10. Correlation Ethnopharmacology: Antimicrobial Activity

Ten species out of the eleven most cited Lamiaceae are used in the Lebanese traditional medicine as antiseptic or antimicrobial agents. Some are even cited specifically as antifungals (3 out of 11). Our results corroborate the antimicrobial indications forCoridothymus capitatus,Origanum syriacum,Lavandula stoechas,Satureja thymbra, andThymbra spicata, indicating that the use of these plant species is most likely linked to the antimicrobial potential of their VOCs. For example, the flowering parts ofC. capitatus are used as antiseptic and to treat dermatosis, and our results showed that the EO of the flowering tops can be considered active on all strains tested. The flowering parts ofO. syriacum,S. thymbra, andT. spicata are also used in Lebanon as antiseptic and antimicrobial agents and their EOs proved to be notably active againstS. aureus,C. albicans, andT. rubrum (Table 5).


## 4. Conclusion

In conclusion, the ethnobotanical and ethnopharmacological survey of the Lamiaceae plants confirmed that their medical values are widely acknowledged among herbalists and rural communities and that this family of plants is still frequently used in the traditional medicine of Lebanon to treat many ailments, including microbial infections.This study highlights thein vitro antimicrobial activity of some Lebanese Lamiaceae EOs against human pathogens. The antimicrobial potential of these EOs originates from their high content in either thymol or carvacrol. These results validate the traditional antimicrobial use of Lamiaceae and lead us to believe that the use of the most active ones of these plants (or their EOs) can be promoted for the treatment of mycoses under topic applications. It should be noted that Lamiaceae herbs have high consumption in the traditional medicine in Lebanon. This might indicate innocuousness [69] although toxicological studies on these species should be encouraged.



---

*Source: 2547169-2016-12-08.xml*